Skip to main content

Advertisement

Log in

INFLAMMATION

The wasting hormone GDF15 frees up fat to fight infection

  • News & Views
  • Published:

From Nature Metabolism

View current issue Submit your manuscript

GDF15 is an anorectic hormone that signals organismal stress to the brain. New data suggest that GDF15 enhances tolerance to acute inflammation by modulating liver lipid metabolism and triglyceride availability in mice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1: GDF15 increases triglyceride mobilisation, thus promoting survival under severe infective stresses.

References

  1. O’Rahilly, S. Cell Metab. 26, 807–808 (2017).

    Article  Google Scholar 

  2. Tsai, V. W. W., Husaini, Y., Sainsbury, A., Brown, D. A. & Breit, S. N. Cell Metab. 28, 353–368 (2018).

    Article  CAS  Google Scholar 

  3. Hsu, J. Y. et al. Nature 550, 255–259 (2017).

    Article  Google Scholar 

  4. Yang, L. et al. Nat. Med. 23, 1158–1166 (2017).

    Article  CAS  Google Scholar 

  5. Emmerson, P. J. et al. Nat. Med. 23, 1215–1219 (2017).

    Article  CAS  Google Scholar 

  6. Mullican, S. E. et al. Nat. Med. 23, 1150–1157 (2017).

    Article  CAS  Google Scholar 

  7. Johnen, H. et al. Nat. Med. 13, 1333–1340 (2007).

    Article  CAS  Google Scholar 

  8. Luan, H. H. et al. Cell 178, 1231–1244.e11 (2019).

    Article  CAS  Google Scholar 

  9. Santos, I. et al. Preprint at bioRxiv https://doi.org/10.1101/613901 (2019).

  10. Patel, S. et al. Cell Metab. 29, 707–718.e8 (2019).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Stephen O’Rahilly.

Ethics declarations

Competing interests

S.O.R. is an employee of the University of Cambridge and has provided remunerated consultancy services to the following pharmaceutical companies with an active or potential interest in GDF15: Pfizer, AstraZeneca, MedImmune and Novo-Nordisk. S.M.L. has no relevant conflicts of interest to declare.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lockhart, S.M., O’Rahilly, S. The wasting hormone GDF15 frees up fat to fight infection. Nat Metab 1, 935–936 (2019). https://doi.org/10.1038/s42255-019-0131-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s42255-019-0131-y

  • Springer Nature Limited

This article is cited by

Navigation